Bonalive Biomaterials
Anna Sahlberg is an experienced professional in quality management and clinical studies, currently serving as Quality Manager at Bonalive Biomaterials since March 2021. Prior to this role, Anna held the position of Clinical Study Manager at PerkinElmer, Inc. from January 2016 to March 2021. Anna's academic background includes extensive research as a PhD student at the University of Turku from January 2012 to January 2015, as well as similar roles at the National Institute for Health and Welfare and the National Public Health Institute between 2009 and 2008. Anna earned a Master of Science degree while studying at the University of Turku from 1998 to 2014, specializing in Cell/Cellular and Molecular Biology.
This person is not in any teams
Bonalive Biomaterials
As the world seeks answers to the growing threat of antibiotic resistance, Bonalive represents a new standard in patient care. Evolving at the intersection of technology and human biology, our Smart Healing™ technologies reduce antibiotic treatments and enable a better quality of life for patients. Smart Healing™ encompasses our commitment to our customers. It defines everything we do, in providing patients and surgeons well-proven and safe bone regenerative products in orthopedics, trauma, spine, septic bone and ear surgery. It's time to heal smarter. #SmartHealing For indications, contraindications, warnings and precautions related to Bonalive® products refer to the IFU within the product package. This site is not intended for US customers.